What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary areas of study are Internal medicine, Transplantation, Kidney transplantation, Surgery and Immunology.
His biological study spans a wide range of topics, including Gastroenterology and Ribavirin.
His studies in Transplantation integrate themes in fields like Clinical endpoint, Randomized controlled trial, Cohort and Sirolimus.
His Kidney transplantation study combines topics in areas such as Therapeutic drug monitoring, Regimen, Pathology, Nephropathy and Ciclosporin.
The concepts of his Surgery study are interwoven with issues in Immunosuppression, Urology and Renal function.
His Immunology research is multidisciplinary, incorporating perspectives in Liver disease, Organ transplantation and Hepatitis E virus.
His most cited work include:
- Hepatitis E virus and chronic hepatitis in organ-transplant recipients. (922 citations)
- A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). (677 citations)
- Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. (459 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Transplantation, Kidney transplantation, Surgery and Gastroenterology.
His Internal medicine study integrates concerns from other disciplines, such as Immunology and Hepatitis C virus.
He focuses mostly in the field of Transplantation, narrowing it down to matters related to Urology and, in some cases, Tacrolimus, Everolimus and Kidney transplant.
The study incorporates disciplines such as Immunosuppression, Rituximab, Mycophenolic acid and Calcineurin in addition to Kidney transplantation.
He works mostly in the field of Surgery, limiting it down to concerns involving Renal function and, occasionally, Creatinine.
His Gastroenterology study combines topics from a wide range of disciplines, such as Ribavirin, Anemia and Pathology.
He most often published in these fields:
- Internal medicine (46.98%)
- Transplantation (40.80%)
- Kidney transplantation (38.79%)
What were the highlights of his more recent work (between 2015-2021)?
- Kidney transplantation (38.79%)
- Internal medicine (46.98%)
- Gastroenterology (29.74%)
In recent papers he was focusing on the following fields of study:
Lionel Rostaing focuses on Kidney transplantation, Internal medicine, Gastroenterology, Urology and Immunosuppression.
Transplantation, Kidney and Surgery are inherently bound to his Kidney transplantation studies.
His work deals with themes such as Antibody, Rituximab and Oncology, which intersect with Internal medicine.
The various areas that Lionel Rostaing examines in his Gastroenterology study include Daclatasvir, Incidence, Sofosbuvir, Group B and Group A.
Lionel Rostaing focuses mostly in the field of Urology, narrowing it down to topics relating to Renal function and, in certain cases, Kidney disease, Kidney donation and Creatinine.
As a part of the same scientific family, Lionel Rostaing mostly works in the field of Immunosuppression, focusing on Belatacept and, on occasion, Abatacept.
Between 2015 and 2021, his most popular works were:
- Belatacept and Long-Term Outcomes in Kidney Transplantation. (369 citations)
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial (185 citations)
- Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. (155 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
The scientist’s investigation covers issues in Kidney transplantation, Internal medicine, Tacrolimus, Transplantation and Urology.
The subject of his Kidney transplantation research is within the realm of Surgery.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Hepatitis C virus and Virology.
He has researched Tacrolimus in several fields, including Extended release, Pharmacogenetics and Mycophenolic acid.
His Transplantation research is multidisciplinary, incorporating perspectives in Immunology, Treatment outcome, Multiple drug resistance and Isoantibodies.
His Urology study combines topics from a wide range of disciplines, such as Pharmacokinetics, CYP3A5 and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
